Pay in 4 interest-free payments of $5.36 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
10 In this review, we have summarized the complex therapeutic landscape of NAFLD/NASH and compared the different drug classes and pathway targets, focusing on those compounds that are in late-stage clinical development and by definition are better placed to succeed in the race for the first FDA-approved and specific therapeutic option against NASH
Preston, R
Enhance Liver Fat Metabolism: It appears to play a crucial role in reducing hepatic steatosis, or the buildup of fat in the liver
The procedure is carefully controlled for temperature and timing, with incubations typically ranging from 1 to 2 h at room temperature to overnight settings at 4C, depending on the target analyte
These studies continue to expand understanding of integrated metabolic signaling pathways
Journal of Investigative Medicine, 70 (1), 513
US$ 22.73
US$ 27.57
US$ 21.73
US$ 25.70
US$ 25.17
US$ 22.83
US$ 28.62
US$ 28.59
US$ 23.10
